Innovative treatments for lipoprotein(a) may transform cardiovascular risk management. These advancements could reshape heart health assessments.
Cholesterol: Pharmaceutical Companies Bet on Lp(a) for Heart Drugs
Pharmaceutical companies are focusing on a lesser-known form of cholesterol, Lp(a), to create new heart medications. This shift could impact…
